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ABSTRACT 
Obese subjects often present a low-grade chronic inflammation in the white adipose 
tissue, which seems to play an important role in the initiation and development of 
obesity-related diseases. It has been reported that this inflammatory process may be due 
to a hypoxic state occuring whithin this tissue. Oxygen is used in current medicine as a 
treatment for several conditions. The aim of this study was to analyze the effects of 95% 
O2 on specific metabolic variables and on the expression of some adipokines on murine 
adipocytes. 3T3-L1 adipocytes were exposed during 48 h to different treatments: 95% 
O2 hyperoxia (HPx group), CoCl2 (CoCl2 group), hyperoxia with CoCl2 (HPx+CoCl2 
group) and 1%O2 hypoxia (Hx group). Cell viability, intracellular ROS content, glucose 
utilization, lactate and glycerol concentrations were measured. Also, mRNA expression 
of HIF-1, GLUT-1, ANGPTL4, PPAR-, adiponectin, IL-6 and MCP-1 genes was 
analyzed. Importantly, 95% O2 decreased cell viability and increased intracellular ROS 
production. Also, glycerol and lactate release were significantly increased and 
decreased, respectively, in HPx treated cells. This treatment also provoked a down-
regulation of GLUT-1 and ANGPTL-4, while IL-6 and MCP-1 were up-regulated. 
Exposure to a hyperoxia of 95% O2 seemed to provoke an inflammatory response in 
adipocytes. The two hypoxia-inducing conditions (CoCl2 and 1% O2) produced 
different outcomes in metabolic measurements as well as in the expression of some 
genes (GLUT-1, ANPGTL4, PPAR- and adiponectin), while it remained similar in 
others (HIF-1, IL-6 and MCP-1). Indeed, hyperoxia increased significantly the ROS 
levels and the lipolytic activity, while it reduced lactate production. In addition to the 
effects on inflammation, the changes in GLUT-1, ANGPTL4 and PPAR- genes let 
suppose that hyperoxia may be beneficial for the hypertrophied adipose tissues of obese 
subjects and for improving insulin sensitivity. 
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INTRODUCTION 
Obesity is a major metabolic disorder commonly accompanied by the onset and 
development of other important diseases such as type 2 diabetes, artheriosclerosis and 
several common cancers (1). These events are often associated with a chronic low-grade 
inflammation in white adipose tissue. Indeed, is now recognized that obesity can induce 
an aberrant production of several inflammatory markers such as IL-6, MCP-1 or TNF-
, which seem to play a causative role in the development of obesity-associated insulin 
resistance and cardiovascular disorders (2, 3). 
In this context, in 2004 it was reported that hypoxia occurs in adipose tissue in obesity 
(4). Further investigations have corroborated this hypothesis, demonstrating a lower 
partial pressure of O2 in adipose tissue in the state of obesity in rodents and humans (5, 
6). Indeed, white adipose tissue expansion in obesity appears to impair the growth of 
adipocytes in size and number, resulting in an increase distance to the vasculature and a 
reduction of O2 tension whithin this tissue. In the following years, this adipose tissue 
hypoxia has been proposed as a possible factor that could play an important role in 
promoting inflammatory mechanisms in this tissue (7).  
In this context, O2 is used in current medicine as a treatment for several conditions (8, 
9), as well as ozone (O3) used under controlled conditions (10). Thus, normobaric and 
hyperbaric oxygen therapies (NBOT and HBOT, respectively) are important techniques 
under continuous investigation. Studies in animals have demonstrated that the treatment 
with hyperoxia might produce beneficial effects in different metabolic disorders, such 
as protecting the rat brain tissue against ischemia reperfusion injury (11), reducing 
severity of colitis (12) or ameliorating hemorrhagic shock-induced renal failure by 
decreasing intrarenal hypoxia and improving renal functions (13). Regarding 
inflammation, several studies have shown that hyperoxia can decrease the expression of 
some pro-inflammatory genes in different organs and cell types (14, 15). Some 
investigations have also demonstrated that HBOT attenuates pro-inflammatory cytokine 
production of systemic inflammation in animal models (16, 17). These findings are in 
agreement with HBOT studies carried out in ex vivo cell cultures (15, 18). 
Taking all these studies into account, where high O2 levels seem to produce beneficial 
effects on inflammatory markers, it was hypothesized that hyperoxia could be used as a 
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specific therapeutic intervention for the improvement of obesity state (19). To our 
knowledge, there are no available data regarding the effects of a hyperoxic treatment on 
murine adipocytes. Therefore, in this study we investigated the effects of 95% of O2, 
alone or in combination with cobalt chloride (as a hypoxia-generating agent), in the 
expression of some genes and in the regulation of specific metabolic variables in 
hypoxic adipocytes. This research was designed in order to understand the possible role 
and mechanisms of hyperoxia in combating low O2 tension in the adipose tissue of 
obese patients. 
 
MATERIAL AND METHODS 
Cell culture  
This research was carried out in 3T3-L1 mouse preadipocytes, that were cultured with 
Dulbecco’s minimal essential media (DMEM) containing 4.5 g/L glucose and 
supplemented with 10% calf bovine serum. Two days after full confluence, cells were 
cultured in twelve-well plates. Their differentiation into adipocytes was induced by 
treating cells for 2 days with 0.5 mM isobutylmethylxanthine, 1 μM dexamethasone and 
10 μg/ml insulin in DMEM supplemented with 10% fetal bovine serum (FBS), and then 
for 2 days with 10 μg/ml insulin in the same media. Thereafter, cells were maintained 
and re-fed every 2-3 days with FBS without any hormones until 14 days after 
differentiation induction, when between 80 and 90% of the cells exhibited the adipocyte 
phenotype. Also, 100 units/ml penicillin and 100 µg/ml streptomycin were added to all 
media. Cells were always maintained in a CytoGROW GLP incubator (Sanyo, San 
Diego, CA, USA) at 37ºC in a humidified atmosphere containing 5% CO2. 
Treatments 
After 14 days post-differentiation, adipocytes were exposed to four different 
experimental treatments: environmental hyperoxia with 95% O2/5% CO2 (HPx group), 
CoCl2 (a hypoxia mimetic which stabilizes HIF-1 (20)). Besides, another group with 
environment hypoxia (1% O2) was added to compare whether CoCl2 could mimic the 
effects produced by real hypoxia. 
at a concentration of 100 µM (CoCl2 group), hyperoxia with CoCl2 (HPx+CoCl2 group) 
and ambient hypoxia with 1% O2/94% N2/5% CO2 (Hx group). Each of these treatments 
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was generated in sealed chambers (Billups-Rosenberg, Del Mar, CA, USA) at 37ºC 
during 48 h. Non-treated cells placed in a standard incubator with 21% O2/5% CO2 were 
used as reference (Control group). After the experimental treatments, culture media 
were collected and stored at -80ºC for further measurements. 
Cell viability assay and ROS determination  
Cell viability was measured with the lactate dehydrogenase (LDH) Cytotoxicity Assay 
Kit at 48 h according to manufacturer’s instructions (Cayman Chemical Company, Ann 
Arbor, USA). 
To determine intracellular ROS concentration, 2',7'-dichlorofluorescein (DCFH) was 
used following a protocol described elsewhere (21). This protocol, which measures 
H2O2 production, is commonly used as a surrogate of ROS generation (22). Briefly, 
cells were incubated with 10 mM DCFH for 40 min at 37ºC in 5% CO2, frozen for at 
least 1 h at -80ºC and then lysed with 1000 μl lysis buffer (150 mM NaCl, 0.1% Triton, 
and 10 mM Tris). Finally, 200 μl of each lysate were loaded on a 96-well black plate 
and fluorescence intensity was measured using a Fluoroskan Ascent FL (Thermo Fisher 
Scientific, Waltham, MA) at an excitation wavelength of 485 nm and at an emission of 
530 nm.  
Measurement of metabolic markers 
The glucose (HK-CP kit; Horiba, Montpellier, France), lactate (ABX Diagnostic, 
Montpellier, France) and glycerol (GLY 105; Randox Laboratories, Antrim, UK) 
concentrations were measured from culture medium samples with a PENTRA C200 
auto-analyzer (Horiba, Montpellier, France) after the 48 h treatment. The adipocyte 
glucose utilization was estimated by the difference between the content of glucose in the 
culture media at the beginning and at the end of the experiment, as previously described 
(21).  
RT-PCR analyses 
Total RNA was isolated from all samples using Trizol according to manufacturer’s 
instructions (Invitrogen, Paisley, UK). Purified total RNA from adipocytes was then 
treated with DNAse (DNAfree kit; Ambion Inc., Austin, USA) and used to generate 
cDNA with M-MLV reverse transcriptase (Invitrogen, Paisley, UK). Real-time PCR 
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was performed in an ABI PRISM 7000 HT Sequence Detection System (Applied 
Biosystems, California, USA). Taqman probes for mouse HIF-1, GLUT-1, 
ANGPTL4, PPAR-, adiponectin, IL-6 and MCP-1 were also supplied by Applied 
Biosystems (California, USA). Moreover, it has been previously established that 
hypoxia can alter mRNA expression levels of some standard genes (23). Therefore, we 
considered necessary to characterize the suitability of various housekeeping genes to 
serve as internal RNA controls. Thus, the expression of 18s, cyclophilin, RNA 
polymerase II and 28s was determined, the latter being selected as the internal control 
because it demonstrated no significant expression changes after different treatments 
(data not shown). All procedures were performed according to a previously described 
protocol (24).  
Statistical analysis 
All data was evaluated using the Kruskal-Wallis test. When interaction was detected, 
the U Mann-Whitney test was used for group comparisons. All results are expressed as 
mean ± standard deviation (SD). Overall, 6 cell culture experiments were performed 
and the reported data come from a representative experiment with n = 6 as stated in all 
figures. Association analyses for selected biochemical markers and gene expression 
values were performed using the Spearman test. A probability of p<0.05 was set up for 
determining statistically significant differences. The statistical analyses were performed 
using SPSS 15 (Chicago, USA) and GraphPad Prism 5.0 (San Diego, USA) software. 
 
RESULTS 
Cell viability and ROS assessments  
The activity of LDH was determined in the conditioned cell media in order to 
investigate the potential cytotoxicity of the applied treatments. As shown in Fig. 1, cell 
viability of 3T3-L1 adipocytes significantly decreased with both hyperoxia and hypoxia 
treatments. However, CoCl2 did not show differences when compared to the control 
group and seemed to be protective against cell death when cells were treated with 
hyperoxia.  
FIGURE 1 
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Furthermore, intracellular ROS production, corrected by cell viability, was significantly 
increased only by the hyperoxia exposure, while the other treatments did not show 
differences when compared to control (Fig. 2). 
FIGURE 2 
 
Culture media determinations  
Glucose utilization, lactate production, and glycerol release of isolated adipocytes were 
determined after the 48 h treatment and were corrected by cell viability. Glycerol 
production was enhanced by both hyperoxia and hypoxia treatments, while it was 
significantly decreased by CoCl2 (Fig. 3A). Glucose utilization was decreased by the 
CoCl2 treatment and increased by hypoxia (Fig. 3B). Moreover, there was a significant 
elevation in lactate release in HPx+CoCl2 and Hx groups, while HPx and CoCl2 
treatments significantly decreased it (Fig. 3C). In all three biochemical markers, 
hyperoxia counteracted the effect of CoCl2. A high association between glucose 
utilization and lactate release was found (r=0.607; p<0.01). Moreover, these two 
biochemical parameters were also strongly correlated with GLUT-1 gene expression 
(r=0.486; p<0.01 and r=0.639; p<0.001, respectively).  
FIGURE 3 
 
Gene expression 
Regarding gene expression, no changes were observed in HIF-1 mRNA levels in each 
of the four treatments when compared to control (Fig. 4A). A significant decrease in the 
expression of GLUT-1 was observed in HPx, while it was up-regulated in HPx+CoCl2 
and Hx groups. There was also a down-regulation of ANGPTL4 mRNA when treated 
with HPx, HPx+CoCl2 and Hx, while no changes were observed with CoCl2. PPAR- 
mRNA expression was down-regulated only by the hypoxia treatment (Fig. 4A). An 
association between GLUT-1 and glucose utilization (r=0.9; p<0.03) was found in the 
HPx group. 
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To determine whether these treatments induced changes on inflammatory adipokines, 
mRNA expression of adiponectin, MCP-1 and IL-6 was measured (Fig. 4B). Thus, 
adiponectin expression was down-regulated by Hx and HPx+CoCl2, but no changes 
were observed with HPx and CoCl2 treatments separately, showing that these two 
factors could provoke different situations if they act together. Finally, MCP-1 and IL-6 
mRNA expression were both up-regulated by HPx. Unexpectedly, these two 
proinflammatory adipokines were down-regulated by the Hx group. CoCl2 treatment 
decreased the expression of MCP-1, but did not change IL-6 expression. In this two 
proinflammatory adipokines, HPx seemed to revert the effect of CoCl2, as it can be 
observed in the HPx+CoCl2 group. Interestingly, a highly positive correlation between 
IL-6 and MCP-1 mRNA levels and glycerol release was found (r=0.864; p<0.001 and 
r=0.845; p<0.001, respectively) considering C and HPx groups. Furthermore, 
associations between the expression of PPAR- with HIF-1 (r=0.597; p<0.001) and IL-6 
(r=0.577; p<0.001) were found.  
FIGURES 4A and 4B 
 
DISCUSSION 
The adipose tissue becomes poorly oxygenated in obese subjects leading to 
inflammatory processes and metabolic syndrome features in these subjects (7), although 
a decrease in adipose tissue O2 tension may not always occur (25). In the current trial, 
the effects of hyperoxia in chemical-hypoxic adipocytes were investigated an approach 
to counteract the hypoxic alterations that often occur in an expanded adipose tissue. 
The 48-h hyperoxia exposure produced a significant cell death respect to control. In 
other experiment of our group, a 24-h exposure did not cause significant differences in 
cell death (26). Thus, cell damage caused by hyperoxia exposure could be related to the 
duration of the treatment. On the other hand, CoCl2 did not affect cell viability. 
Interestingly, CoCl2 has been observed to be protective to cell death in some conditions 
(27). In this experiment, CoCl2 also reverted the cell death of adipocytes induced by 
hyperoxia. Furthermore, 1% O2 hypoxia significantly decreased this variable as 
previously reported (28).  
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The enhanced generation of intracellular ROS by hyperoxia may lead to the cell death 
observed (29). Nevertheless, the HPx+CoCl2 group did not show significant differences 
on intracellular ROS release, being consistent with the cell viability result. Although it 
has been established that both environmental and chemical hypoxia increase ROS 
generation in adipocytes (30, 31), no differences in intracellular ROS release were 
found in Hx and CoCl2 treatments. Regarding CoCl2, this observation could be 
explained by the time and dose used (31). 
The Hx group induced an increase on lipolysis, glucose utilization and lactate release, as 
it has been previously described (28, 32). It is known that in anaerobic conditions the 
cell is not able to oxidize glucose fully through mitochondrial oxidation and in 
consequence, there is a lower adenosine-5’-triphosphate (ATP) production with respect 
to respiration. To compensate this lack of ATP, cells may increase their glucose uptake. 
This mechanism could explain the response of glucose utilization observed with 
hyperoxia. Probably, a higher O2 availability might induce the ATP production mainly 
through the aerobic metabolism and therefore, no compensatory pathways need to be 
activated. This outcome seems to be in accordance with the significant reduction 
observed in lactate production in hyperoxic conditions, and goes in the same direction 
as other investigations observed in other tissues (33). In obesity, it has been found that 
adipocyte-derived lactate by the hypoxic state may constitute another link between this 
disease and its associated pathologies (32). In this sense, since hyperoxia decreased 
lactate release in adipocytes, it might ameliorate some obesity-associated complications. 
Furthermore, a high association between glucose utilization and lactate release was 
found, confirming the relationship of these two metabolic pathways with O2 tension. 
Contrary to expectations, the hypoxic mimetic CoCl2 did not follow the tendency 
observed with 1% O2 on these biochemical parameters. 
It is known that glucose uptake and GLUT-1 mRNA expression are increased in 
hypoxia (28, 34), as we observed in our experiment. Under hyperoxic conditions, 
GLUT-1 expression was significantly decreased by adipocytes. Interestingly, the 
expression of this glucose transporter did not change with the occurrence of CoCl2, 
although it was significantly increased when both conditions were placed together 
(HPx+CoCl2 group). An association of the expression of this gene with glucose 
utilization was also found, suggesting that a higher O2 tension might also be able to 
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participate on glucose metabolism in adipose tissue, as previously observed in muscle 
cells (35). Furthermore, ANGPTL4 is a gene involved in the regulation of plasma 
triacylglycerides metabolism (36). Thus, a down-regulation in ANGPTL4, as it occurred 
with hyperoxia, may contribute to ameliorate some metabolic disorders. The analysis of 
Hx and CoCl2 groups revealed a decrease in the expression of this gene. Nevertheless, 
these results should be taken with caution, since they differ from experiments in human 
adipocytes (37). 
Several trials have confirmed that the exposure to high O2 concentrations seems to 
produce beneficial effects on inflammatory markers in both, cell culture (15) and animal 
models (17). Although a significant increase in the expression of these type of cytokines 
has been also reported (38, 39). Nevertheless, these effects were not evident until the 
animals were treated for at least 48 h of hyperoxia, suggesting that inflammation is 
dependent on the duration of the O2 exposure. Contrary to our initial expectations, 
mRNA levels of pro-inflammatory markers IL-6 and MCP-1 were up-regulated by 
hyperoxia. The induction of adipocyte death may be a mechanism by which hyperoxia 
could contribute to up-regulate the expression of these genes in 3T3-L1 adipocytes. 
Another possible explanation could be that free fatty acids released by lipolysis might 
contribute to this inflammatory response, as demonstrated in other cell types (40). This 
outcome is in accordance with a strong relationship observed in the current experiment 
between the expression of IL-6 and MCP-1 genes and glycerol release concerning C and 
HPx groups. Furthermore, the HPx+CoCl2 group increased MCP-1 and IL-6 gene 
expressions with respect to CoCl2 group, suggesting that hyperoxia could exert a 
dominant effect in the expression of these genes in hypoxic conditions. Even though 
hyperoxia provoked the up-regulation of pro-inflammatory adipokines, this treatment 
did not modify the expression of adiponectin, known to be down-regulated by IL-6 (41). 
However, since the expression of this adipokine did not change with HPx and CoCl2 
independently, it was significantly decreased in the HPx+CoCl2 group, probably due to 
cell stress produced by the combined effect of both conditions.  
Adiponectin is also an important selective controlled modulator of insulin sensitivity 
whose expression is enhanced by PPAR- (42). In our experiment, PPAR- mRNA 
expression tended to increase in hyperoxia and this event may prevent the decrease of 
adiponectin expression by IL-6. Furthermore, it has been proposed that HBOT could 
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increase insulin sensitivity in type 2 diabetes patients (43). On the other hand, Hx 
treatment produced a down-regulation of mRNA levels of PPAR-. This outcome is in 
agreement with the results from Kim et al., who suggested that hypoxic condition 
attenuates adipocyte differentiation inhibiting PPAR- expression by the activation of 
AMPK, which impairs clonal expansion phase (44). 
Contradictory data has been found regarding the effects of CoCl2 and ambient hypoxia. 
Perhaps the concentration of this hypoxia mimetic (100 µM) was not high enough to 
produce the same effects in 3T3-L1 mature adipocytes as 1% O2 did. Since not always 
mRNA levels and protein secretion are related, data at the protein level could 
complement the value of this research, which was specifically focused on the 
transcriptomic effects of O2 supply in adipocytes.  
In summary, to the authors knowledge this is the first study to combine the 
measurements of metabolic markers and the expression of genes involved in glucose 
and lipid metabolism as well as the inflammatory response in 3T3-L1 adipocytes 
exposed to hyperoxia. Indeed, hyperoxia increased significantly the ROS levels and the 
lipolytic activity, while it reduced lactate production. The changes in genes not involved 
in inflammation such as GLUT-1 and ANGPTL4 and PPAR- let suppose that 
hyperoxia may be beneficial for the hypertrophied adipose tissues of obese subjects and 
for improving insulin sensitivity. 
 
  
 12
ACKNOWLEDGMENTS 
The authors wish to thank the EXPLORA-MICINN (Ministerio de Ciencia e 
Innovación), SAF2010-11630-E, the “Línea Especial” (LE/97) from the University of 
Navarra (Spain) and the “Asociación de Amigos de la Universidad de Navarra’’ for 
financial support. Also CIBERobn and RETICS Schemes are credited. Finally, the 
authors are grateful for the expert technical assistance of Verónica Ciaurriz and to 
Richard Marks (University of Surrey, Guilford) for technical support and for reviewing 
the English of the final version of the manuscript. 
 
CONFLICT OF INTERESTS 
All the authors declare that there are no competing financial interests regarding the 
contents of this article. 
 13
FIGURE LEGENDS  
 
Figure 1. Cellular integrity in control and treated groups was measured at 48 h. One 
symbol means p<0.05, two symbols p<0.01. * Treatment groups vs Control;  HPx vs 
CoCl2;  HPx vs HPx+CoCl2;  CoCl2 vs Hx. Data (n=6) are expressed as mean ± SD.  
  
Figure 2. Intracellular ROS content at 48 h in 3T3-L1 adipocytes (14 days post-
differentiation). Two symbols mean p<0.01. * Treatment groups vs Control;  HPx vs 
CoCl2;  HPx vs HPx+CoCl2;  HPx vs Hx. Data (n=6) are expressed as mean ± SD. 
 
Figure 3. Effect of different treatments on glucose utilization, glycerol and lactate 
release in 3T3-L1 adipocytes (14 days post-differentiation). One symbol means p<0.05, 
two symbols p<0.01. * Treatment groups vs Control;  HPx vs CoCl2;  HPx vs 
HPx+CoCl2; # CoCl2 vs HPx+CoCl2;  HPx vs Hx;  CoCl2 vs Hx. Data (n=6) are 
expressed as mean ± SD. 
 
Figure 4. (A) Gene expression analysis of HIF-1α, GLUT-1, ANGPTL4 and PPAR- 
and (B) of inflammatory genes IL-6, MCP-1 and adiponectin at 48 h in 3T3-L1 
adipocytes (14 days post-differentiation). Two symbols mean p<0.01. * Treatment 
groups vs Control;  HPx vs CoCl2;  HPx vs HPx+CoCl2; # CoCl2 vs HPx+CoCl2;  
HPx vs Hx;  CoCl2 vs Hx. Data (n=6) are expressed as mean ± SD. 
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